• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水性薄膜包衣减少热熔挤出丙烯酸基质中愈创甘油醚的再结晶。

Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.

机构信息

PharmaForm, LLC, Austin, TX 78758, USA.

出版信息

Drug Dev Ind Pharm. 2010 Feb;36(2):218-26. doi: 10.3109/03639040903271277.

DOI:10.3109/03639040903271277
PMID:19877992
Abstract

OBJECTIVES

This study investigated the effect of aqueous film coating on the recrystallization of guaifenesin from acrylic, hot-melt extruded matrix tablets.

METHODS

After hot-melt extrusion, matrix tablets were film-coated with either hypromellose or ethylcellulose. The effects of the coating polymer, curing and storage conditions, polymer weight gain, and core guaifenesin concentration on guaifenesin recrystallization were investigated.

RESULTS

The presence of either film coating on the guaifenesin-containing tablets was found to prolong the onset time of drug crystallization. The coating polymer was the most important factor determining the delay in the onset of crystallization, with the more hydrophilic polymer, hypromellose, having a higher solubilization potential for the guaifenesin and delaying crystallization for longer period (3 or 6 months in tablets stored at 40 degrees C or 25 degrees C, respectively) than the more hydrophobic ethylcellulose, which displayed a lower solubilization potential for guaifenesin (crystal growth on tablets cured for 2 hours at 60 degrees C occurred within 3 weeks, whereas uncoated tablets displayed surface crystal growth after 30 minutes). Crystal morphology was also affected by the film coating. Elevated temperatures during both curing and storage, incomplete film coalescence, and high core drug concentrations all contributed to an earlier onset of crystal growth.

摘要

目的

本研究考察了水膜包衣对丙烯酸热熔挤出基质片中小檗碱再结晶的影响。

方法

热熔挤出后,用羟丙甲纤维素或乙基纤维素对基质片进行包衣。考察了包衣聚合物、固化和储存条件、聚合物增重以及核心小檗碱浓度对小檗碱再结晶的影响。

结果

发现含有小檗碱的片剂表面的任何一种包衣都能延长药物结晶的起始时间。包衣聚合物是决定结晶起始延迟的最重要因素,亲水性更强的聚合物羟丙甲纤维素对小檗碱的溶解能力更高,因此结晶延迟时间更长(分别在 40°C 或 25°C 下储存 3 或 6 个月),而疏水性更强的乙基纤维素对小檗碱的溶解能力较低(在 60°C 下固化 2 小时的片剂上,结晶生长在 3 周内发生,而未包衣的片剂在 30 分钟后出现表面结晶生长)。包衣还会影响晶体形态。固化和储存过程中的高温、不完全的薄膜融合以及高芯药物浓度都会导致晶体生长更早开始。

相似文献

1
Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.水性薄膜包衣减少热熔挤出丙烯酸基质中愈创甘油醚的再结晶。
Drug Dev Ind Pharm. 2010 Feb;36(2):218-26. doi: 10.3109/03639040903271277.
2
Crystal growth formation in melt extrudates.熔体挤出物中的晶体生长形成
Int J Pharm. 2007 Aug 16;341(1-2):162-72. doi: 10.1016/j.ijpharm.2007.04.008. Epub 2007 Apr 19.
3
The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE.异质成核对含有 Eudragit L10055 或 Acryl-EZE 的熔融挤出物中愈创甘油醚表面结晶的影响。
Eur J Pharm Biopharm. 2010 May;75(1):71-8. doi: 10.1016/j.ejpb.2009.12.001. Epub 2009 Dec 6.
4
Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.工艺参数和处方因素对用尤特奇L 100-55包衣的片剂药物释放的影响。
Eur J Pharm Biopharm. 2007 Sep;67(2):464-75. doi: 10.1016/j.ejpb.2007.02.021. Epub 2007 Mar 7.
5
The manufacture and characterisation of hot-melt extruded enteric tablets.热熔挤出肠溶片剂的制造与表征
Eur J Pharm Biopharm. 2008 May;69(1):264-73. doi: 10.1016/j.ejpb.2007.11.001. Epub 2007 Nov 13.
6
Characterization of the film formation of the dry coating process.干涂层工艺成膜特性
Eur J Pharm Biopharm. 2007 Sep;67(2):449-57. doi: 10.1016/j.ejpb.2007.02.023. Epub 2007 Mar 12.
7
Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.采用新型静电干粉包衣工艺对片剂进行 Eudragit(®)RS/RL 的缓释包衣。
Int J Pharm. 2010 Oct 31;399(1-2):37-43. doi: 10.1016/j.ijpharm.2010.07.047. Epub 2010 Aug 1.
8
A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.一种用于制备应用于片剂的掩味和防潮膜的新型粉末包衣工艺。
Int J Pharm. 2004 Jul 26;279(1-2):127-39. doi: 10.1016/j.ijpharm.2004.04.015.
9
Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.柠檬酸一水合物作为熔融挤出型骨架片中的释放调节剂。
Int J Pharm. 2008 Sep 1;361(1-2):158-68. doi: 10.1016/j.ijpharm.2008.05.035. Epub 2008 Jun 5.
10
Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: formulation and storage stability.格列齐特缓释骨架微丸的制备及体外评价:处方及稳定性研究。
Drug Dev Ind Pharm. 2010 Jul;36(7):814-22. doi: 10.3109/03639040903520967.